Comparison

IchorBio

ichorbio

ichorbio – Antibodies and biosimilars for in vivo studies

The British company ichorbio is a reliable manufacturer of monoclonal antibodies. Ichorbio products are manufactured in a state-of-the-art cGMP laboratory and subjected to strict quality tests. To ensure a consistently high product quality, the antibodies are produced in an ISO9001 certified facility.

Antibodies for in vivo applications

Ichorbio attaches particular importance to the production of antibodies for in vivo application with the least possible effects on the test animals. Therefore, all products contain a low level of endotoxin, high purity and low aggregation. The ultra-low endotoxin antibodies are tested for mouse pathogens and do not contain any preservatives or carrier proteins. The purity is over 95% at an endotoxin content of ≤0,5 EU / mg.

Overview of PD-1-Antibody-Portfolio by ichorbio:

Art. No.: Art. Name:
ICH1182-5MG Mouse Anti-­Mouse PD-­1 Antibody (RMP1-­14) [ICH1182]
ICH1183-5MG Mouse anti-­Mouse PD-­L1 antibody (10F.9G2) [ICH1183]
ICH1132-5MG Anti-­Mouse PD-­1 In Vivo Antibody -­ Low Endotoxin (RMP1-­14)
ICH1091-5MG Anti-­Mouse PD-­1 In Vivo Antibody -­ Low Endotoxin (29F.1A12)
ICH1182D265A* Mouse Anti-Mouse PD-1 Antibody (RMP1-14) D265A [ICH1182D265A]
ICH1132EC5† Anti-­Mouse PD-­1 In Vivo Antibody -­ Low Endotoxin (RMP1-­14) 5MG/­ML
ICH1132EC10† Anti-­Mouse PD-­1 In Vivo Antibody -­ Low Endotoxin (RMP1-­14) 10MG/­ML

Research Grade Biosimilars

Our partner develops and produces a growing number of biosimilars. These are successors to originally biological drugs. Biological drugs are complex and gained from living cells. Also known as biologics, they are used for example in cancer therapy. Unlike chemically produced generics, biosimilars are not completely identical to their originals. Biosimilars are being used more and more, especially in the fight against cancer. TNF tumor necrosis factor is a multifunctional signaling substance of the immune system that is involved in local and systemic inflammation. There are currently three anti-TNF antibodies approved to inhibit TNF alpha: infliximab, adalimumab and golimumab. Ichorbio has developed two versions of adalimumab - a standard biosimilar and an Fc-silenced version. An infliximab biosimilar has also been developed for research purposes.

Overview of ichorbio's bioisimilar portfolio:

SKU: Biosimilar
ICH4001-5MG Adalimumab Biosimilar - Research Grade
ICH4002-5MG Alemtuzumab Biosimilar - Research Grade
ICH4003-5MG Bevacizumab Biosimilar - Research Grade
ICH4004-5MG Cetuximab Biosimilar - Research Grade
ICH4005-5MG Eculizumab Biosimilar - Research Grade
ICH4006-5MG Infliximab Biosimilar - Research Grade
ICH4007-5MG Matuzumab Biosimilar - Research Grade
ICH4008-5MG Nimotuzumab Biosimilar - Research Grade
ICH4009-5MG Nivolumab Biosimilar - Research Grade
ICH4010-5MG Omalizumab Biosimilar - Research Grade
ICH4011-5MG Rituximab Biosimilar - Research Grade
ICH4012-5MG Tocilizumab Biosimilar - Research Grade
ICH4013-5MG Trastuzumab Biosimilar - Research Grade
ICH4014-5MG Ado-trastuzumab emtansine Biosimilar - Research Grade
ICH4015-5MG Aflibercept Biosimilar - Research Grade
ICH4016-5MG Alirocumab Biosimilar - Research Grade
ICH4017-5MG Avelumab Biosimilar - Research Grade
ICH4018-5MG Atezolizumab Biosimilar - Research Grade
ICH4019-5MG Denosumab Biosimilar - Research Grade
ICH4022-5MG Etanercept Biosimilar - Research Grade
ICH4023-5MG Evolocumab Biosimilar - Research Grade
ICH4025-5MG Ipilimumab Biosimilar - Research Grade
ICH4026-5MG Obinutuzumab Biosimilar - Research Grade
ICH4027-5MG Ofatumumab Biosimilar - Research Grade
ICH4028-5MG Panitumumab Biosimilar - Research Grade
ICH4029-5MG Pembrolizumab Biosimilar - Research Grade
ICH4030-5MG Pertuzumab Biosimilar - Research Grade
ICH4031-5MG Ranibizumab Biosimilar - Research Grade
ICH4032-5MG Ramucirumab Biosimilar - Research Grade
ICH4033-5MG Secukinumab Biosimilar - Research Grade
ICH4034-5MG Ustekinumab Biosimilar - Research Grade
ICH4035-5MG Vedolizumab Biosimilar - Research Grade
ICH5001-5MG Sintilimab Biosimilar -­ Research Grade
ICH5002-5MG Toripalimab Biosimilar -­ Research Grade
ICH5003-5MG Camrelizumab Biosimilar -­ Research Grade
ICH5004-5MG Tislelizumab Biosimilar -­ Research Grade
ICH5005-5MG Durvalumab Biosimilar -­ Research Grade

ichorRed® and ichorGreen® nucleic acid gel stains are non-mutagenic, fluorescent nucleic acid gel stains of the third generation. They are ideal for staining dsDNA, ssDNA or RNA in agarose gels or polyacrylamide gels. The highly toxic traditional ethidium bromide can be replaced directly with ichorRed® without changing the existing imaging system. Gel staining is still compatible with downstream applications such as gel extraction and cloning. ichorRed® is efficiently removed from the DNA by phenol / chloroform extraction and ethanol precipitation. The non-toxic red and green colors are available in different sizes and can be disposed of safely and easily. They are spectrally compatible with standard laboratory instruments.

Search for products by ichorbio

ichorbio products by Product Category

ichorbio products by Research Area

Any other questions?

If you have any questions, we are always at your disposal.
If you have not found a product, just send us a request and we'll take care of the rest.
Feel free to use our online services for your request.

 

Our Online-Service

 

Product Request
Recall Request
Easy Ordering
Bulk Request